103 related articles for article (PubMed ID: 33148119)
1. Improving direct pharmacist counseling rates for oral oncolytic medications at an outpatient oncology clinic.
Hayes DJ; Moore JE
J Oncol Pharm Pract; 2021 Dec; 27(8):1861-1868. PubMed ID: 33148119
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
Finn A; Bondarenka C; Edwards K; Hartwell R; Letton C; Perez A
J Oncol Pharm Pract; 2017 Dec; 23(8):563-574. PubMed ID: 27573921
[TBL] [Abstract][Full Text] [Related]
3. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
4. Impact of an Oncology Clinical Pharmacist Specialist in an Outpatient Multiple Myeloma Clinic.
Virani A; Schlei Z; Gleason C; Ackermann M; Wolfe B; Major S; McIver A; Jakubowiak AJ; Jasielec J; Parsad S
Clin Lymphoma Myeloma Leuk; 2020 Sep; 20(9):e543-e546. PubMed ID: 32605900
[TBL] [Abstract][Full Text] [Related]
5. Impact of Pharmacist-Led Patient Education in an Ambulatory Cancer Center: A Pilot Quality Improvement Project.
Park D; Patel S; Yum K; Smith CB; Tsao CK; Kim S
J Pharm Pract; 2022 Apr; 35(2):268-273. PubMed ID: 33153388
[TBL] [Abstract][Full Text] [Related]
6. 2018 Hematology/Oncology Pharmacist Association Best Practices for the Management of Oral Oncolytic Therapy: Pharmacy Practice Standard.
Mackler E; Segal EM; Muluneh B; Jeffers K; Carmichael J
J Oncol Pract; 2019 Apr; 15(4):e346-e355. PubMed ID: 30860937
[TBL] [Abstract][Full Text] [Related]
7. Incorporating a clinical oncology pharmacist into an ambulatory care pharmacy in pediatric hematology-oncology and transplant clinic: Assessment and significance.
Ali K; Al-Quteimat O; Naseem R; Malhi SM; Wajdi M; Jahan N; Ansari SH; Shamsi TS
J Oncol Pharm Pract; 2021 Jun; 27(4):815-820. PubMed ID: 32633660
[TBL] [Abstract][Full Text] [Related]
8. Improving adherence to the Epic Beacon ambulatory workflow.
Chackunkal E; Dhanapal Vogel V; Grycki M; Kostoff D
J Oncol Pharm Pract; 2017 Jun; 23(4):273-277. PubMed ID: 26988246
[TBL] [Abstract][Full Text] [Related]
9. Oncology Pharmacist Opportunities: Closing the Gap in Quality Care.
Vulaj V; Hough S; Bedard L; Farris K; Mackler E
J Oncol Pract; 2018 Jun; 14(6):e403-e411. PubMed ID: 29298114
[TBL] [Abstract][Full Text] [Related]
10. Expansion of pharmacist practice in oral oncolytic therapy with a collaborative practice agreement.
Wright AL; Matta SF; Kerr JR
J Oncol Pharm Pract; 2020 Dec; 26(8):1886-1893. PubMed ID: 32075505
[TBL] [Abstract][Full Text] [Related]
11. Pharmacist-Led Discharge Medication Counseling and its Corresponding Impact on Medication Adherence and Hospital Readmission Rates.
Cunningham S; Kinsey JD
Innov Pharm; 2020; 11(3):. PubMed ID: 34007627
[No Abstract] [Full Text] [Related]
12. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
13. Implementation of a medication therapy management collaborative within a pediatric health system.
Sneed G; Kappeler K; Gilmore T; Kuhn C
J Am Pharm Assoc (2003); 2018; 58(4S):S114-S119. PubMed ID: 29871801
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist impact on medication dosing and billable coding accuracy in outpatients with chronic kidney disease.
Cypes IN; Prohaska ES; Melton BL
J Am Pharm Assoc (2003); 2021; 61(2):e153-e158. PubMed ID: 33160871
[TBL] [Abstract][Full Text] [Related]
15. Integration of clinical pharmacists into an ambulatory, pediatric hematology/oncology/transplant clinic.
Defoe KD; Jupp J; Leslie T
J Oncol Pharm Pract; 2019 Apr; 25(3):607-612. PubMed ID: 29451420
[TBL] [Abstract][Full Text] [Related]
16. Assessment of workflow redesign in community pharmacy.
Angelo LB; Ferreri SP
J Am Pharm Assoc (2003); 2005; 45(2):145-50. PubMed ID: 15868756
[TBL] [Abstract][Full Text] [Related]
17. Utilization of simulated patients to assess diabetes and asthma counseling practices among community pharmacists in Qatar.
Paravattil B; Kheir N; Yousif A
Int J Clin Pharm; 2017 Aug; 39(4):759-768. PubMed ID: 28466396
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxis.
Reslan Z; Lindsay J; Kerridge I; Gellatly R
Int J Clin Pharm; 2020 Dec; 42(6):1412-1418. PubMed ID: 33009604
[TBL] [Abstract][Full Text] [Related]
19. Home medication management review in outpatients with chronic diseases in Jordan: a randomized control trial.
Basheti IA; Al-Qudah RA; Obeidat NM; Bulatova NR
Int J Clin Pharm; 2016 Apr; 38(2):404-13. PubMed ID: 26960406
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of pharmacist interventions in a head and neck medical oncology clinic.
Lau KM; Saunders IM; Sacco AG; Barnachea LC
J Oncol Pharm Pract; 2020 Sep; 26(6):1390-1396. PubMed ID: 31937188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
